|
|
||||||||
1 Michael E. DeBakey Institute for Comparative Cardiovascular Science, Department of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, 77843; and 2 Center for Microvascular and Lymphatic Studies, Department of Anesthesiology, The University of Texas Medical School, Houston, Texas 77030
| |
ABSTRACT |
|---|
|
|
|---|
Myocardial edema occurs in many pathological conditions. We
hypothesized that protein washdown at the myocardial microvascular exchange barrier would change the distribution of interstitial proteins
from large to small molecules and diminish the effect of washdown on
the colloid osmotic pressure (COP) of interstitial fluid and lymph.
Dogs were instrumented with coronary sinus balloon-tipped catheters and
myocardial lymphatic cannulas to manipulate myocardial lymph flow and
to collect lymph. Myocardial venous pressure was elevated by balloon
inflation to increase transmicrovascular fluid flux and myocardial
lymph flow. COP of lymph was measured directly and was also calculated
from protein concentration. Decreases occurred in both protein
concentration and COP of lymph. The proportion of lymph protein
accounted for by albumin increased significantly, whereas that
accounted for by
-lipoprotein decreased significantly. The change in
the calculated plasma-to-lymph COP gradient was significantly greater
than the change in the measured COP gradient. We conclude that the
change in the distribution of interstitial fluid protein species
decreases the effect of protein washdown on interstitial fluid COP and
limits its effectiveness as a defense mechanism against myocardial
edema formation.
interstitial heart disease; colloid osmotic pressure
| |
INTRODUCTION |
|---|
|
|
|---|
MYOCARDIAL
INTERSTITIAL EDEMA develops as a consequence of coronary sinus
hypertension, pulmonary hypertension, arterial hypertension, myocardial
infarction, heart transplant rejection, hypoproteinemia, and
cardioplegic arrest (2-4, 8, 9, 13, 15, 23). Myocardial edema formation impairs left ventricular systolic and diastolic function (4, 8, 15). Mechanisms that defend against myocardial edema formation following an edematogenic stress include an increase in interstitial hydrostatic pressure
(19), a decrease in interstitial colloid osmotic pressure
(COP) (6), an increase in lymph flow (4, 6,
8), and an increase in flow of interstitial fluid across the
epicardium (11, 12, 18). The first two of these mechanisms
act by altering the pressure gradients that regulate
transmicrovascular filtration as represented in the Starling-Landis
equation
|
(1) |
d is the osmotic reflection coefficient
with a value between 0 and 1, and
p and
int are the COPs exerted by plasma and interstitial
fluid, respectively (10). Lp
represents the ease with which water traverses the microvascular
barrier. The
d represents the effectiveness with
which the colloid osmotic gradient is exerted across the microvascular
barrier (10).
The phenomenon termed "protein washdown", the decrease in protein concentration of lymph following an increase in JV, has been demonstrated to occur in the myocardium (6). This process, when combined with an increase in lymph flow, decreases the protein concentration and the COP of interstitial fluid. As can be seen from Eq. 1, this change acts to decrease JV, thus moderating edema formation.
The relationship between JV and the
protein concentration of lymph has been modeled as
|
(2) |
f is the solvent-drag reflection coefficient with a
value between 0 and 1, and PS is the microvascular protein permeability-surface area product (21). Equation 2 demonstrates that an increase in JV will
act to decrease PS/JV and, thereby, decrease CL with respect to CP such that
CL/CP decreases and approaches (1
f).
Plasma contains a wide variety of protein species that differ
in size and charge as well as function. The effectiveness of the
microvascular membrane as a barrier to movement of these protein species differs as a function of these physical properties. Therefore, the terms
f and P from Eq. 2 will be
different for each species of protein molecule. Because interstitial
fluid is an ultrafiltrate of plasma, the distribution of proteins found
in interstitial fluid is a function of the distribution found in plasma
as well as the ease with which each protein species crosses the
microvascular barrier. This distribution would be expected to change
following an increase in JV, because the
relationship between CL/CP and JV is different for each protein species.
The refractive index of a biological solution is a reliable and
accurate indicator of protein concentration (16). Because of the documented relationship between COP and protein concentration (7, 14), the ease of measuring refractive index, and the difficulty associated with sampling interstitial fluid,
int is often estimated by measuring CL.
However,
int is dependent on both the concentration and
the type of proteins within that fluid. It has been clearly
demonstrated that albumin generates a higher COP per unit mass than
larger protein molecules (17). This is because albumin has
more particles per unit mass and because it induces a greater
redistribution of ions via the Donnan ion effect (17).
In a study utilizing coronary sinus occlusion to induce myocardial edema, Laine and Granger (6) observed a substantial decrease in lymph protein concentration but a relatively small decrease in myocardial lymph COP. They further noted a shift in the distribution of lymph protein after washdown in favor of smaller protein species. We hypothesized that an increase in JV within the myocardium would cause a significantly greater decrease in the interstitial fluid concentration of large protein molecules than small ones, resulting in a shift in the distribution of lymph proteins to smaller molecules. We further hypothesized that, because of this distribution change, the effect of increased JV on the measured COP of lymph would be significantly less than the COP calculated from CL, thereby moderating the effectiveness of protein washdown as a defense mechanism against myocardial edema.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Animal preparation. All procedures were approved by the University of Texas Animal Welfare Committee and were consistent with the National Institutes of Health Guide for the Care and Use of Laboratory Animals. Six mongrel dogs with body mass exceeding 15 kg and of either sex were used. Anesthesia was induced with thiopental sodium (20 mg/kg) and maintained with 1.0 to 2.5% halothane. After intubation, the dogs were ventilated with a respirator (Harvard Apparatus, South Natick, MA) set to deliver room air at a volume of 25 ml/kg and at a rate appropriate to maintain arterial PCO2 between 35 and 40 mmHg. We introduced a Swan-Ganz catheter (5-Fr) into the cranial (superior) vena cava via the right jugular vein. A fluid-filled catheter connected to a pressure transducer was introduced into the femoral artery and the tip advanced to the abdominal aorta. All data from the transducer were recorded through a transducer amplifier and analog-digital converter (MacLab, Division of ADInstruments, Milford, MA) directly to a computer (Macintosh Quadra 950, Apple Computer, Cupertino, CA) executing Chart software (MacLab). Arterial pressure was monitored as an indicator of depth of anesthesia. A fluid-filled catheter was placed via the femoral vein into the caudal (inferior) vena cava for fluid or drug administration and for blood collection. After median sternotomy, we advanced the previously inserted Swan-Ganz catheter into the coronary sinus and sutured it to the free wall of the sinus so that it did not compromise coronary sinus flow. The prenodal lymphatic trunk draining the left ventricle was identified and cannulated as previously described (6, 19). This lymphatic vessel has been estimated to drain ~85% of total cardiac lymph (9). We administered heparin sodium intravenously (300 U/kg body wt). The lymph cannula was connected via fluid-filled tubing to a graduated pipette set at a height equal to that of the cannulation site
Physiological measurements.
The myocardial lymphatic cannulation allowed assessment of lymph flow
and collection of lymph for determination of COP and the concentrations
of total protein, albumin, and
-lipoprotein. Blood was collected
from the femoral vein catheter and centrifuged to produce plasma. COPs
of lymph and plasma were measured directly using a colloid osmometer
(model 4400, Wescor, Logan, UT). Total protein concentrations of lymph
and plasma were determined by refractometry (AO TS Meter, American
Optical, Buffalo, NY). To facilitate measurement of concentrations
<2.5 g/dl, a plot was constructed from the scales on the refractometer
relating protein concentration to refractive index. Because this
relationship is linear, we measured the refractive index for each
sample and used the derived relationship to calculate the protein
concentration. COP values were also determined by calculation using the
curvilinear relationship between COP and plasma protein concentration
(PC) reported by Landis and Pappenheimer (7)
|
(3) |
Experimental protocol. Lymph and plasma samples were obtained for the determination of baseline values for COP and concentrations of total protein and for electrophoresis. Baseline values for lymph flow rate were also determined. The Swan-Ganz catheter balloon was then inflated with oil so that the coronary sinus flow was reduced and myocardial microvascular pressure was increased. This technique reliably induces acute myocardial edema formation and increased cardiac lymph flow (4, 6, 15). One hour after balloon inflation, lymph flow was measured and lymph and plasma samples were collected for determination of COP and total protein concentrations and for electrophoresis.
Data analysis.
All values are reported as means ± SE unless otherwise noted.
Albumin and
-lipoprotein concentrations were calculated as fractions, determined by electrophoresis, of the total protein concentration. We calculated plasma-to-lymph gradients (the difference between the plasma and lymph) for measured and calculated COP values
and compared them using a paired t-test. Baseline and
postocclusion values for each variable were also compared using a
paired t-test. We performed data analysis with a computer
executing SigmaStat (SSPS, Chicago, IL). A value of P < 0.05 was considered significant.
| |
RESULTS |
|---|
|
|
|---|
Partial occlusion of the coronary sinus resulted in a
5.6 ± 0.7 (SD)-fold increase in lymph flow. These data were not
further analyzed because the magnitude of both lymph flow and the
change in lymph flow are affected by cannula height (5).
Sinus occlusion caused no significant change in COP or protein
concentrations in plasma but caused significant decreases in COP and
concentrations of total protein, albumin, and
-lipoprotein in lymph
(Table 1). The measured and calculated
plasma-to-lymph gradients for COP increased significantly following
coronary sinus occlusion (Table 2). The
increase in the COP gradient was significantly greater for calculated
values (8.3 ± 0.7 mmHg) than for measured values (2.7 ± 1.0 mmHg) (P < 0.01). The proportion of the total protein in lymph accounted for by albumin increased significantly following occlusion, whereas that accounted for by
-lipoprotein decreased significantly (Table 2).
|
|
| |
DISCUSSION |
|---|
|
|
|---|
Coronary sinus occlusion has been demonstrated to be a reliable model for induction of myocardial edema. Coronary sinus occlusion results in a decrease in cardiac lymph protein concentration and increases in the following variables: coronary venous and capillary pressures, myocardial microvascular filtration rate, myocardial interstitial water content and pressure, cardiac lymph flow, and fluid transudation across the epicardium (4, 6, 15, 18).
Our data demonstrate that the protein washdown that results from
increased microvascular filtration in the myocardium is accompanied by
a significant change in the distribution of protein species in lymph.
This change is characterized by a proportional increase in small
protein molecules, primarily represented by albumin (Stokes-Einstein radius of 37 Å; 69,000 mol wt), and a decrease in large protein molecules represented by
-lipoprotein (Stokes-Einstein radius of 120 Å; >2,000,000 mol wt) (7, 21). As a result of the shift
to smaller, more osmotically active protein molecules, the plasma-to-lymph gradient for measured COP increased by only 35%, whereas the COP gradient calculated from protein concentration increased by over 150%. This reduced response of lymph COP to protein
washdown limits the effectiveness of protein washdown as a defense
mechanism against edema in the myocardium.
Figure 1 demonstrates COP of myocardial
lymph plotted as a function of protein concentration from baseline and
postocclusion data. As a reference, the relationships between COP and
the concentrations of total protein, albumin, and globulin calculated
by Landis and Pappenheimer (7) and by Navar and Navar
(14) are also included. Figure 1 demonstrates that the
washdown-induced change in protein distribution causes the lymph
COP-protein concentration relationship to move across rather than down
the traditional curves. Extrapolation of this relationship to the
zero-zero intercept is not helpful because further increases in the
microvascular filtration rate would drive the lymph protein
concentration to some filtration independent value rather than zero
(21). The washdown-induced change in lymph protein
distribution should not affect the accuracy of refractive index as a
measure of protein concentration because refractive index is affected
by protein mass rather than particle number (16). These
results further suggest that protein concentration of myocardial lymph
is an unreliable indicator of COP and any assessment of lymph COP
should be made by direct measurement.
|
In contrast to the results of our analysis of lymph, a comparison of
measured and calculated values for plasma COP (Fig.
2) demonstrates a highly predictive
relationship. This finding is expected because the equation for
calculating COP reported by Pappenheimer and Landis (Eq. 3)
(7) was derived using plasma values for protein
concentration and COP.
|
Complete assessment of the effect of protein washdown on the
transmicrovascular COP gradient (
p

int) must include the effect of the
d. The value for
d is dependent on the
permeability of the barrier to protein such that it equals "zero"
when the barrier is completely permeable to protein and equals
"one" when the barrier is completely impermeable. The
d value for total protein has not been determined for
the myocardial microvasculature; however, estimated values of 0.75 and
0.96 have been reported for albumin and
-lipoprotein, respectively
(1, 6).
Protein washdown functions as a protective mechanism against edema formation by decreasing the interstitial protein concentration and, therefore, the COP of interstitial fluid. This change, in turn, moderates JV by decreasing the total transmicrovascular pressure gradient (Eq. 1).
A clearer understanding of the relative importance of protein washdown as an antiedema mechanism can be gained by using the evaluation method described by Taylor (20), where the response of each protective mechanism to an edematogenic stress is calculated in terms of transmicrovascular pressure gradient. We performed this analysis using the following assumptions: the myocardial microvascular reflection coefficient was equal to one, and the observed increase in lymph flow was representative of the actual physiological response with the understanding that the magnitude of the lymph flow increase through a cannulated lymphatic vessel is dependent on the height of the outflow cannula (5). Furthermore, we modified Taylor's approach to include the change in epicardial transudation as well as myocardial lymph flow in the estimation of steady-state microvascular filtration (18). Using data from the current study and previously published information, we calculated the following relative contributions of antiedema mechanisms following coronary sinus occlusion: increased myocardial interstitial hydrostatic pressure represented 86%, increased lymph flow and transepicardial transudation represented 6%, and increased COP gradient represented 8%. These estimates correspond closely to previous estimates for the heart (20, 22)
The data presented here demonstrate that, during protein washdown associated with increases in microvascular filtration, the distribution of protein species in lymph changes and the lymph protein concentration-COP relationship moves from a curve describing large protein molecules to one describing smaller molecules. The effectiveness of protein washdown in reducing the COP of the myocardial interstitial fluid under these conditions is diminished, and the decline in the interstitial fluid COP will be overestimated if the change in lymph protein concentration is used as a guide.
| |
ACKNOWLEDGEMENTS |
|---|
This study was supported by National Heart, Lung, and Blood Institute Grants HL-36115 and HL-01999 and the American Heart Association.
| |
FOOTNOTES |
|---|
Address for reprint requests and other correspondence: R. H. Stewart, Dept. of Veterinary Physiology and Pharmacology, Texas A&M Univ., College Station, TX 77843-4466.
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 15 October 1999; accepted in final form 24 April 2000.
| |
REFERENCES |
|---|
|
|
|---|
1.
Blackshear, G,
and
Vargas F.
Filtration coefficient of heart capillaries obtained from osmotic and hydrostatic pressure gradients.
Microvasc Res
17:
S84-S84,
1979.
2.
Davis, KL,
Mehlhorn U,
Laine GA,
and
Allen SJ.
Myocardial edema, left ventricular function, and pulmonary hypertension.
J Appl Physiol
78:
132-137,
1995
3.
Hallgren, R,
Gerdin B,
Tengblad A,
and
Tufveson G.
Accumulation of hyaluronan (hyaluronic acid) in myocardial interstitial tissue parallels development of transplantational edema in heart allografts in rats.
J Clin Invest
85:
668-673,
1990.
4.
Laine, GA,
and
Allen SJ.
Left ventricular myocardial edema: lymph flow, interstitial fibrosis, and cardiac function.
Circ Res
68:
1713-1721,
1991
5.
Laine, GA,
Drake RE,
Zavisca FG,
and
Gabel JC.
Effect of lymphatic cannula outflow height on lung microvascular permeability estimations.
J Appl Physiol
57:
1412-1416,
1984
6.
Laine, GA,
and
Granger HJ.
Microvascular, interstitial, and lymphatic interactions in normal heart.
Am J Physiol Heart Circ Physiol
249:
H834-H842,
1985.
7.
Landis, EM,
and
Pappenheimer JR.
Exchange of substances through capillary walls.
In: Handbook of Physiology. Circulation. Washington, DC: Am. Physiol. Soc, 1963, sect. 2, vol. II, chapt. 29, p. 961-1034.
8.
Mehlhorn, U,
Allen SJ,
Adams D,
Davis KL,
Gogola GR,
de Vivie ER,
and
Laine GA.
Normothermic continuous antegrade blood cardioplegia does not prevent myocardial edema and cardiac dysfunction.
Circulation
92:
1939-1946,
1995.
9.
Mehlhorn, U,
Davis KL,
Burke EJ,
Adams D,
Laine GA,
and
Allen SJ.
Impact of cardiopulmonary bypass and cardioplegic arrest on myocardial lymphatic function.
Am J Physiol Heart Circ Physiol
268:
H178-H183,
1995
10.
Michel, CC.
Fluid movements through capillary walls.
In: Handbook of Physiology. The Cardiovascular System. Microcirculation. Bethesda, MD: Am. Physiol. Soc, 1984, sect. 2, vol. IV. pt 1, chapt. 9, p. 375-409.
11.
Miller, AJ,
Pick R,
and
Johnson PJ.
The production of acute pericardial effusion: the effects of various degrees of interference with venous blood and lymph drainage from the heart muscle in the dog.
Am J Cardiol
28:
463-466,
1971[ISI][Medline].
12.
Miller, AJ,
Pick R,
and
Johnson PJ.
The rates of formation of cardiac lymph and pericardial fluid after the production of myocardial venous congestion in dogs.
Lymphology
5:
156-160,
1972[ISI][Medline].
13.
Miyamoto, M,
McClure DE,
Schertel ER,
Andrews PJ,
Jones GA,
Pratt JW,
Ross P,
and
Myerowitz PD.
Effects of hypoproteinemia-induced myocardial edema on left ventricular function.
Am J Physiol Heart Circ Physiol
274:
H937-H944,
1998
14.
Navar, PD,
and
Navar LG.
Relationship between colloid osmotic pressure and plasma protein concentration in the dog.
Am J Physiol Heart Circ Physiol
233:
H295-H298,
1977.
15.
Pratt, JW,
Schertel ER,
Schaefer SL,
Esham KE,
McClure DE,
Heck CF,
and
Myerowitz PD.
Acute transient coronary sinus hypertension impairs left ventricular function and induces myocardial edema.
Am J Physiol Heart Circ Physiol
271:
H834-H841,
1996
16.
Rubini, ME,
and
Wolf AV.
Refractometric determination of total solids and water of serum and urine.
J Biol Chem
225:
869-876,
1957
17.
Scatchard, G,
Batchelder AC,
and
Brown A.
Chemical, clinical and immunological studies on the products of human plasma fractionation. VI: The osmotic pressure of plasma and of serum albumin.
J Clin Invest
23:
458-464,
1944.
18.
Stewart, RH,
Rohn DA,
Allen SJ,
and
Laine GA.
Basic determinants of epicardial transudation.
Am J Physiol Heart Circ Physiol
273:
H1408-H1414,
1997
19.
Stewart, RH,
Rohn DA,
Mehlhorn U,
Davis KL,
Allen SJ,
and
Laine GA.
Regulation of microvascular filtration in the myocardium by interstitial fluid pressure.
Am J Physiol Regulatory Integrative Comp Physiol
271:
R1465-R1469,
1996
20.
Taylor, AE.
The lymphatic edema safety factor: the role of edema dependent lymphatic factors (EDLF).
Lymphology
23:
111-123,
1990[ISI][Medline].
21.
Taylor, AE,
and
Granger DN.
Exchange of macromolecules across the microcirculation.
In: Handbook of Physiology. The Cardiovascular System. Bethesda, MD: Am. Physiol. Soc, 1984, sect. 2, vol. IV, pt. 1, chapt. 11, p. 467-520.
22.
Taylor, AE,
and
Townsley MI.
Evaluation of the Starling fluid flux equation.
News Physiol Sci
2:
48-52,
1987
23.
Waldenstrom, A,
Martinussen HJ,
Gerdin B,
and
Hallgren R.
Accumulation of hyaluronan and tissue edema in experimental myocardial infarction.
J Clin Invest
88:
1622-1628,
1991.
This article has been cited by other articles:
![]() |
U. Mehlhorn, H. J. Geissler, G. A. Laine, and S. J. Allen Myocardial fluid balance Eur. J. Cardiothorac. Surg., December 1, 2001; 20(6): 1220 - 1230. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |